CLDN11 and neoplasm: The results showed that CLDN11 promoter was hypermethylated in seven NPC tumor tissues (34.62%–85.34%, average 62.64%) compared with that of the paired adjacent normal tissues (1.20%–42.07%, average 10%; Fig. 2a).